{"product_id":"xr-ipsc-derived-vascularized-lung-organoid-differentiation-kit","title":"XR iPSC-Derived Vascularized Lung Organoid Differentiation Kit","description":"\u003c!--\nSEO TITLE:\nCerebral Organoid Differentiation Kit | Human iPSC\n\nMETA DESCRIPTION:\nGenerate human cerebral organoids from hPSCs using a chemically defined four-stage workflow for EB formation, neural induction, expansion, and maturation.\n\nRECOMMENDED URL:\n\/products\/cerebral-organoid-differentiation-kit\n\nPRIMARY KEYWORDS:\nCerebral Organoid Differentiation Kit\nCerebral Organoid Kit\nHuman Cerebral Organoid\niPSC Cerebral Organoid\nBrain Organoid Culture\n\nSECONDARY KEYWORDS:\nHuman Brain Organoid\nWhole Brain Organoid\nhPSC-Derived Cerebral Organoid\nCerebral Organoid Culture Kit\nNeural Organoid Culture\nEmbryoid Body Formation\nNeural Induction\nNeural Expansion\nOrganoid Maturation\nChemically Defined Medium\nHuman Pluripotent Stem Cells\nCortical Development\nForebrain Development\n3D Brain Model\nHuman Neural Development\nLong-Term Organoid Culture\n--\u003e\n\u003cstyle\u003e\n  \/* 现代专业风全局样式 *\/\n  .pdp-container {\n    font-family: -apple-system, BlinkMacSystemFont, \"Segoe UI\", Roboto, Helvetica, Arial, sans-serif;\n    color: #333333;\n    line-height: 1.6;\n    max-width: 1200px;\n    margin: 0 auto;\n    padding: 15px;\n  }\n\n  \/* 标题样式升级 *\/\n  .pdp-container h2 {\n    font-size: 24px;\n    color: #0B3C5D;\n    border-bottom: 2px solid #328CC1;\n    padding-bottom: 8px;\n    margin-top: 40px;\n    margin-bottom: 20px;\n    font-weight: 600;\n  }\n\n  .pdp-container h3 {\n    font-size: 18px;\n    color: #1D2731;\n    margin-top: 30px;\n    margin-bottom: 15px;\n    font-weight: 600;\n  }\n\n  \/* 段落与列表 *\/\n  .pdp-container p {\n    margin-bottom: 16px;\n    font-size: 15px;\n    color: #4A4A4A;\n    text-align: justify;\n  }\n\n  .pdp-container ul,\n  .pdp-container ol {\n    padding-left: 20px;\n    margin-bottom: 24px;\n  }\n\n  .pdp-container li {\n    margin-bottom: 10px;\n    font-size: 15px;\n    color: #4A4A4A;\n  }\n\n  .pdp-container ul li {\n    list-style-type: square;\n  }\n\n  .pdp-container li p {\n    margin-bottom: 0;\n    display: inline;\n  }\n\n  \/* 移动端表格响应式滑动容器 *\/\n  .pdp-table-responsive {\n    width: 100%;\n    overflow-x: auto;\n    -webkit-overflow-scrolling: touch;\n    margin: 25px 0;\n    border: 1px solid #E0E0E0;\n    border-radius: 6px;\n    box-shadow: 0 2px 5px rgba(0,0,0,0.05);\n  }\n\n  .pdp-table-responsive::-webkit-scrollbar {\n    height: 6px;\n  }\n\n  .pdp-table-responsive::-webkit-scrollbar-thumb {\n    background-color: #CBCBCB;\n    border-radius: 4px;\n  }\n\n  \/* 专业表格样式 *\/\n  .pdp-table {\n    width: 100%;\n    border-collapse: collapse;\n    min-width: 600px;\n    background-color: #FFFFFF;\n    text-align: left;\n  }\n\n  .pdp-table th,\n  .pdp-table td {\n    padding: 12px 16px;\n    border-bottom: 1px solid #E0E0E0;\n    font-size: 14px;\n    vertical-align: top;\n  }\n\n  .pdp-table th {\n    background-color: #F1F6F9;\n    color: #0B3C5D;\n    font-weight: 600;\n  }\n\n  .pdp-table tr:last-child td {\n    border-bottom: none;\n  }\n\n  .pdp-table tbody tr:nth-child(even) {\n    background-color: #F8F9FA;\n  }\n\n  .pdp-table td strong {\n    color: #0B3C5D;\n    font-weight: 600;\n  }\n\n  \/* 图片自适应安全容器 *\/\n  .pdp-img-container {\n    max-width: 700px;\n    margin: 24px auto;\n    padding: 10px;\n    border: 1px solid #EEEEEE;\n    border-radius: 8px;\n    box-shadow: 0 4px 12px rgba(0, 0, 0, 0.05);\n    background: #FFFFFF;\n    box-sizing: border-box;\n    text-align: center;\n  }\n\n  .pdp-img-container img {\n    max-width: 100%;\n    height: auto;\n    display: block;\n    margin: 0 auto;\n    border-radius: 4px;\n  }\n\n  .pdp-img-placeholder {\n    min-height: 260px;\n    display: flex;\n    align-items: center;\n    justify-content: center;\n    padding: 25px;\n    box-sizing: border-box;\n    border: 1px dashed #B8C5CE;\n    border-radius: 4px;\n    background-color: #F8F9FA;\n    color: #6B7780;\n    font-size: 14px;\n    line-height: 1.6;\n  }\n\n  .pdp-img-caption {\n    margin: 10px 0 0;\n    font-size: 13px !important;\n    color: #6A6A6A !important;\n    text-align: center !important;\n  }\n\n  \/* 流程卡片 *\/\n  .pdp-stage-grid {\n    display: grid;\n    grid-template-columns: repeat(4, minmax(0, 1fr));\n    gap: 14px;\n    margin: 25px 0;\n  }\n\n  .pdp-stage-card {\n    border: 1px solid #DCE5EA;\n    border-radius: 7px;\n    padding: 18px;\n    background-color: #FFFFFF;\n    box-shadow: 0 2px 7px rgba(0,0,0,0.04);\n  }\n\n  .pdp-stage-card strong {\n    display: block;\n    color: #0B3C5D;\n    margin-bottom: 7px;\n    font-size: 15px;\n  }\n\n  .pdp-stage-card span {\n    display: block;\n    color: #4A4A4A;\n    font-size: 14px;\n    line-height: 1.55;\n  }\n\n  \/* 信息提示框 *\/\n  .pdp-note {\n    margin: 24px 0;\n    padding: 16px 18px;\n \n    background-color: #F4F8FB;\n    border-radius: 0 6px 6px 0;\n  }\n\n  .pdp-note p {\n    margin: 0;\n    color: #394B59;\n  }\n\n  \/* FAQ折叠面板 *\/\n  .pdp-container details {\n    background-color: #F8F9FA;\n    border: 1px solid #E0E0E0;\n    border-radius: 6px;\n    margin-bottom: 12px;\n    padding: 14px 18px;\n    transition: all 0.3s ease;\n  }\n\n  .pdp-container details[open] {\n    background-color: #FFFFFF;\n    border-color: #328CC1;\n    box-shadow: 0 4px 10px rgba(50, 140, 193, 0.1);\n  }\n\n  .pdp-container summary {\n    font-weight: 600;\n    color: #0B3C5D;\n    cursor: pointer;\n    font-size: 15px;\n    outline: none;\n    user-select: none;\n  }\n\n  .pdp-container summary:hover {\n    color: #328CC1;\n  }\n\n  .pdp-container details p {\n    margin-top: 12px;\n    margin-bottom: 0;\n    padding-top: 12px;\n    border-top: 1px dashed #E0E0E0;\n    color: #555555;\n  }\n\n  \/* 手机端间距微调 *\/\n  @media (max-width: 900px) {\n    .pdp-stage-grid {\n      grid-template-columns: repeat(2, minmax(0, 1fr));\n    }\n  }\n\n  @media (max-width: 768px) {\n    .pdp-container h2 {\n      font-size: 20px;\n      margin-top: 30px;\n    }\n\n    .pdp-container h3 {\n      font-size: 16px;\n    }\n\n    .pdp-container p,\n    .pdp-container li {\n      font-size: 14px;\n    }\n\n    .pdp-stage-grid {\n      grid-template-columns: 1fr;\n    }\n\n    .pdp-img-placeholder {\n      min-height: 200px;\n    }\n  }\n\u003c\/style\u003e\n\u003cdiv class=\"pdp-container\"\u003e\n\u003ch2\u003eDescription\u003c\/h2\u003e\n\u003cp\u003eGenerating reproducible human brain organoids can be difficult when embryoid bodies form unevenly, neural induction varies between experiments, or developing organoids do not receive the appropriate medium at each stage. These workflow variables can affect organoid morphology, neural lineage development, and the consistency of downstream brain development studies.\u003c\/p\u003e\n\u003cp\u003eXR Cerebral Organoid Differentiation Kit is a chemically defined, stage-specific culture system designed to differentiate human pluripotent stem cells (hPSCs), including induced pluripotent stem cells (iPSCs), into three-dimensional cerebral organoids. The workflow guides cultures through embryoid body formation, neural induction, neural expansion, matrix embedding, and orbital maturation using four dedicated media.\u003c\/p\u003e\n\u003cp\u003eThe resulting hPSC-derived cerebral organoids are described as large, optically dense structures containing multiple lineage characteristics and cortical-like regions. By organizing the differentiation process into clearly defined stages from Day 0 through Day 40 and beyond, the kit provides researchers with a structured brain organoid culture workflow for studying early human neural and cortical development.\u003c\/p\u003e\n\u003cp\u003eThis cerebral organoid culture kit supplies sufficient medium to generate approximately 48 cerebral organoids under the described culture format. It is intended for research applications involving human brain organoid formation, neural tissue development, three-dimensional brain models, and long-term organoid culture.\u003c\/p\u003e\n\u003ch2\u003eSpecifications\u003c\/h2\u003e\n\u003cdiv class=\"pdp-table-responsive\"\u003e\n\u003ctable class=\"pdp-table\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eProduct Name\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eXR Cerebral Organoid Differentiation Kit\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eProduct Type\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eCerebral organoid differentiation medium kit\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eStarting Cell Type\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eHuman pluripotent stem cells, including human iPSCs\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCulture Format\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eThree-dimensional suspension organoid culture\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eDifferentiation System\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eChemically defined, four-stage differentiation workflow\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eStage A\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eEmbryoid body formation\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eStage B\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eNeural induction\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eStage C\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eNeural expansion following matrix embedding\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eStage D\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eCerebral organoid growth and maturation\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCulture Timeline\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eDay 0 to Day 40+, with continued culture according to the required organoid size\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eStarting Confluency\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eApproximately 80% iPSC confluency before differentiation\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eInitial Culture Plate\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e96-well low-attachment U-bottom plate\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eSubsequent Culture Plate\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e24-well low-attachment plate\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eOrbital Culture Speed\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e65–75 rpm from Day 14\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eMedium Replacement\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eEvery other day according to the described workflow\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eApproximate Yield\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eApproximately 48 cerebral organoids per kit\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eGrade\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eFor Research Use Only\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003ch2\u003eKit Components\u003c\/h2\u003e\n\u003cdiv class=\"pdp-table-responsive\"\u003e\n\u003ctable class=\"pdp-table\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eComponent\u003c\/th\u003e\n\u003cth\u003eVolume\u003c\/th\u003e\n\u003cth\u003eWorkflow Stage\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eCerebral Organoid Induction Medium A\u003c\/td\u003e\n\u003ctd\u003e30 mL\u003c\/td\u003e\n\u003ctd\u003eEmbryoid body formation\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCerebral Organoid Induction Medium B\u003c\/td\u003e\n\u003ctd\u003e30 mL\u003c\/td\u003e\n\u003ctd\u003eNeural induction\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCerebral Organoid Induction Medium C\u003c\/td\u003e\n\u003ctd\u003e30 mL\u003c\/td\u003e\n\u003ctd\u003eNeural expansion after matrix embedding\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCerebral Organoid Induction Medium D\u003c\/td\u003e\n\u003ctd\u003e160 mL\u003c\/td\u003e\n\u003ctd\u003eOrbital culture, organoid growth, and maturation\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003ch2\u003eFeatures\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eFour-stage cerebral organoid differentiation workflow covering embryoid body formation, neural induction, neural expansion, and organoid maturation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eChemically defined culture system developed for human pluripotent stem cell differentiation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eCompatible with human iPSC-based cerebral organoid culture workflows\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eStage-specific media help simplify medium selection throughout the differentiation timeline\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eSupports the formation of large, optically dense cerebral organoids with multiple cortical-like regions\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eIncludes sufficient medium for approximately 48 cerebral organoids under the described culture format\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eSupports continued orbital culture beyond Day 40 for organoid growth to the desired experimental size\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eSuitable for three-dimensional human neural development and cerebral tissue modeling research\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eFour-Stage Differentiation Workflow\u003c\/h2\u003e\n\u003cp\u003eThe cerebral organoid differentiation protocol uses four sequential culture stages. Each medium is assigned to a defined developmental window to support the transition from undifferentiated human iPSCs to developing three-dimensional cerebral organoids.\u003c\/p\u003e\n\u003cdiv class=\"pdp-stage-grid\"\u003e\n\u003cdiv class=\"pdp-stage-card\"\u003e\n\u003cstrong\u003eStage 1: EB Formation\u003c\/strong\u003e \u003cspan\u003eDay 0–6\u003cbr\u003eSingle-cell iPSCs are aggregated in low-attachment U-bottom plates using Medium A.\u003c\/span\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pdp-stage-card\"\u003e\n\u003cstrong\u003eStage 2: Neural Induction\u003c\/strong\u003e \u003cspan\u003eDay 7–10\u003cbr\u003eEmbryoid bodies are transferred to low-attachment 24-well plates and cultured in Medium B.\u003c\/span\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pdp-stage-card\"\u003e\n\u003cstrong\u003eStage 3: Neural Expansion\u003c\/strong\u003e \u003cspan\u003eDay 11–13\u003cbr\u003eDeveloping organoids are embedded in matrix and cultured in Medium C.\u003c\/span\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pdp-stage-card\"\u003e\n\u003cstrong\u003eStage 4: Organoid Maturation\u003c\/strong\u003e \u003cspan\u003eDay 14–40+\u003cbr\u003eOrganoids are cultured on an orbital shaker in Medium D to support continued growth.\u003c\/span\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003ch3\u003eDay 0–6: Embryoid Body Formation\u003c\/h3\u003e\n\u003cp\u003eBegin differentiation when the iPSC culture reaches approximately 80% confluency. On Day 0, dissociate the cells into a single-cell suspension and seed them into a 96-well low-attachment U-bottom plate using Cerebral Organoid Induction Medium A. Maintain the cultures through Day 6 and replace the medium every other day.\u003c\/p\u003e\n\u003ch3\u003eDay 7–10: Neural Induction\u003c\/h3\u003e\n\u003cp\u003eOn Day 7, transfer the developing organoids to a 24-well low-attachment plate and replace the culture medium with Cerebral Organoid Induction Medium B. Maintain the organoids under static culture conditions and replace the medium every other day through Day 10.\u003c\/p\u003e\n\u003ch3\u003eDay 11–13: Matrix Embedding and Neural Expansion\u003c\/h3\u003e\n\u003cp\u003eFrom Day 11, embed the developing organoids in an appropriate extracellular matrix material and return them to a 24-well low-attachment plate. Culture the embedded organoids in Cerebral Organoid Induction Medium C under static conditions, replacing the medium every other day.\u003c\/p\u003e\n\u003ch3\u003eDay 14–40+: Orbital Culture and Organoid Maturation\u003c\/h3\u003e\n\u003cp\u003eFrom Day 14, place the 24-well low-attachment plate on an orbital shaker operating at 65–75 rpm. Replace the culture medium with Cerebral Organoid Induction Medium D and continue changing the medium every other day. Cultures may be maintained beyond Day 40 until the cerebral organoids reach the size required for the planned research application.\u003c\/p\u003e\n\u003c!-- IMAGE 2 POSITION: Differentiation timeline and organoid morphology\n     Replace the src value below with the final Shopify CDN image URL.\n\n     Recommended alt:\n     Human iPSC cerebral organoid differentiation timeline showing embryoid body formation neural induction matrix embedding and orbital maturation\n--\u003e\n\u003cdiv class=\"pdp-img-container\" style=\"text-align: center;\"\u003e\u003cimg alt=\"Human iPSC cerebral organoid differentiation timeline showing embryoid body formation neural induction matrix embedding and orbital maturation\" loading=\"lazy\" width=\"1200\" height=\"700\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0521\/5312\/2997\/files\/1_1_b01b9ad9-50c8-48bb-8b4b-44bc90248bf3.jpg?v=1784008344\" style=\"float: none;\"\u003e\u003c\/div\u003e\n\u003cdiv class=\"pdp-note\"\u003e\n\u003cp\u003e\u003cstrong\u003eImportant:\u003c\/strong\u003e The differentiation schedule, culture vessels, medium changes, matrix handling, and orbital shaker settings should be followed consistently to reduce workflow-related variability between cerebral organoid cultures.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003ch2\u003ePerformance Data\u003c\/h2\u003e\n\u003ch3\u003eCerebral Organoid Morphology During Differentiation\u003c\/h3\u003e\n\u003cp\u003eThe documented culture workflow shows progressive morphological changes from adherent iPSC culture to compact embryoid body formation, neural induction, neural tissue expansion, and the development of a larger cerebral organoid by Day 40 and beyond. Matrix embedding is introduced during the neural expansion stage before orbital maturation culture.\u003c\/p\u003e\n\u003ch3\u003eNeural and Cortical Marker Expression\u003c\/h3\u003e\n\u003cp\u003eImmunofluorescence data from the differentiated cerebral organoids include staining for TUJ, PAX6, CTIP2, and FOXG1. Together, these markers provide evidence of neural differentiation, neural progenitor development, cortical neuronal identity, and forebrain-associated tissue characteristics within the organoid cultures.\u003c\/p\u003e\n\u003cdiv class=\"pdp-table-responsive\"\u003e\n\u003ctable class=\"pdp-table\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eMarker\u003c\/th\u003e\n\u003cth\u003eResearch Relevance\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eTUJ\u003c\/td\u003e\n\u003ctd\u003eCommonly used to identify neuronal differentiation and developing neuronal structures\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePAX6\u003c\/td\u003e\n\u003ctd\u003eAssociated with neural progenitor populations and early neuroectodermal development\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCTIP2\u003c\/td\u003e\n\u003ctd\u003eAssociated with deep-layer cortical neuronal identity\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFOXG1\u003c\/td\u003e\n\u003ctd\u003eAssociated with forebrain specification and telencephalic development\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c!-- IMAGE 3 POSITION: Neural marker immunofluorescence panels\n     Replace the src value below with the final Shopify CDN image URL.\n\n     Recommended alt:\n     TUJ PAX6 CTIP2 and FOXG1 immunofluorescence staining in human iPSC derived cerebral organoids\n--\u003e\n\u003cdiv class=\"pdp-img-container\" style=\"text-align: center;\"\u003e\u003cimg height=\"700\" width=\"1200\" loading=\"lazy\" alt=\"TUJ PAX6 CTIP2 and FOXG1 immunofluorescence staining in human iPSC derived cerebral organoids\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0521\/5312\/2997\/files\/1_1_1292c70b-0ed6-4824-9112-1c68ad5dbd95.jpg?v=1784008261\" style=\"float: none;\"\u003e\u003c\/div\u003e\n\u003ch2\u003eApplications\u003c\/h2\u003e\n\u003cp\u003eXR Cerebral Organoid Differentiation Kit is intended for researchers requiring a structured method for generating hPSC-derived cerebral organoids. The resulting three-dimensional neural tissue models may support studies that require human-relevant developmental context beyond conventional two-dimensional neural cell culture.\u003c\/p\u003e\n\u003ch3\u003eHuman Brain Development Research\u003c\/h3\u003e\n\u003cp\u003eHuman cerebral organoids provide a three-dimensional model for investigating early neural development, tissue organization, and the emergence of cortical-like regions. The staged workflow can be used in research examining the transition from pluripotent stem cells through embryoid body formation, neuroectoderm induction, neural progenitor expansion, and cerebral tissue maturation.\u003c\/p\u003e\n\u003ch3\u003eCortical and Forebrain Development Studies\u003c\/h3\u003e\n\u003cp\u003eThe presence of PAX6-, CTIP2-, and FOXG1-associated signals makes these organoids relevant to studies of neural progenitor development, cortical neuronal differentiation, and forebrain-related tissue specification. Researchers may use the system to investigate developmental pathways involved in human cortical and telencephalic organization.\u003c\/p\u003e\n\u003ch3\u003eHuman iPSC Disease Modeling\u003c\/h3\u003e\n\u003cp\u003ePatient-derived or genetically modified iPSC lines may be differentiated into cerebral organoids for comparative research on neurodevelopmental phenotypes. Experimental design should include suitable controls and independent validation because differentiation behavior may vary between iPSC lines.\u003c\/p\u003e\n\u003ch3\u003eGene Editing and Functional Studies\u003c\/h3\u003e\n\u003cp\u003eGene-edited human pluripotent stem cell lines can be incorporated into cerebral organoid workflows to study how selected genetic changes influence neural induction, organoid morphology, marker expression, and three-dimensional tissue development.\u003c\/p\u003e\n\u003ch3\u003eDrug Discovery and Compound Evaluation\u003c\/h3\u003e\n\u003cp\u003eHuman brain organoid models may provide a research platform for preliminary compound evaluation, phenotype-based screening, and studies of developmental responses in three-dimensional neural tissue. Assay suitability, dosing conditions, endpoint selection, and organoid-to-organoid variability should be validated for each screening workflow.\u003c\/p\u003e\n\u003ch3\u003eNeurotoxicity Research\u003c\/h3\u003e\n\u003cp\u003eDeveloping cerebral organoids may be used in research investigating how test compounds influence neural differentiation, tissue morphology, cell viability, or developmental marker expression. This product is intended for research use and is not a validated clinical or diagnostic testing system.\u003c\/p\u003e\n\u003ch3\u003eLong-Term Neural Organoid Culture\u003c\/h3\u003e\n\u003cp\u003eThe Day 40+ maturation stage supports continued orbital culture until the organoids reach the size required for the study. This makes the workflow applicable to research requiring extended cerebral organoid culture and later-stage analysis of neural tissue development.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eHuman cerebral organoid generation from iPSCs and other hPSCs\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eEarly human brain development research\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eCortical development and forebrain specification studies\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eNeural induction and neural progenitor differentiation research\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eThree-dimensional human neural tissue modeling\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eHuman iPSC-based neurodevelopmental disease modeling\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eGene editing and isogenic cell line comparison studies\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003ePhenotype-based drug discovery and compound screening research\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eDevelopmental neurotoxicity research\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eLong-term cerebral organoid culture and maturation studies\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eWhy Use a Stage-Specific Cerebral Organoid Kit?\u003c\/h2\u003e\n\u003cp\u003eCerebral organoid formation requires different culture conditions as cells move from pluripotency toward embryoid body formation, neural induction, tissue expansion, and maturation. Using one general medium throughout the process may not provide the changing developmental signals required at each stage.\u003c\/p\u003e\n\u003cp\u003eXR Cerebral Organoid Differentiation Kit separates the workflow into four dedicated media, helping laboratories organize critical medium transitions and maintain a consistent differentiation schedule. The combination of low-attachment culture, matrix embedding, and orbital maturation provides a complete workflow from human iPSC culture to Day 40+ cerebral organoid formation.\u003c\/p\u003e\n\u003cp\u003eFor laboratories establishing a human brain organoid model, this defined stage structure can simplify experimental planning, reduce the need to prepare multiple differentiation formulations independently, and provide a common workflow for comparing organoid outcomes across experiments.\u003c\/p\u003e\n\u003ch2\u003eCulture Considerations\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eBegin with healthy, undifferentiated human pluripotent stem cell cultures at approximately 80% confluency.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eGenerate a uniform single-cell suspension before seeding the 96-well low-attachment plate.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eMaintain consistent seeding conditions to reduce variation in embryoid body size.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eFollow the specified medium transition schedule for each differentiation stage.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eHandle developing organoids carefully during transfer and matrix embedding.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eMaintain the orbital shaker between 65 and 75 rpm during the maturation stage.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eEvaluate each hPSC line independently because organoid formation efficiency and morphology may vary by cell line.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eUse appropriate morphological, molecular, and immunostaining endpoints to validate organoid identity for the intended application.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eFAQ\u003c\/h2\u003e\n\u003cdetails\u003e\n\u003csummary\u003eWhat is the XR Cerebral Organoid Differentiation Kit used for?\u003c\/summary\u003e\n\u003cp\u003eThe kit is used to differentiate human pluripotent stem cells, including human iPSCs, into three-dimensional cerebral organoids through a staged workflow covering embryoid body formation, neural induction, neural expansion, matrix embedding, and organoid maturation.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003eCan this cerebral organoid kit be used with human iPSCs?\u003c\/summary\u003e\n\u003cp\u003eYes. The workflow is designed for human pluripotent stem cells and specifically describes starting differentiation from an iPSC culture at approximately 80% confluency.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003eIs this a chemically defined cerebral organoid culture system?\u003c\/summary\u003e\n\u003cp\u003eYes. The product is described as a chemically defined differentiation system containing four stage-specific cerebral organoid induction media.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003eHow many cerebral organoids can one kit generate?\u003c\/summary\u003e\n\u003cp\u003eThe supplied medium volumes are intended to generate approximately 48 cerebral organoids when used according to the described culture format and differentiation workflow.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003eHow long does cerebral organoid differentiation take?\u003c\/summary\u003e\n\u003cp\u003eThe documented workflow runs from Day 0 through Day 40 and beyond. Organoids can continue to be cultured after Day 40 until they reach the size required for the research application.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003eWhat are the four stages of cerebral organoid differentiation?\u003c\/summary\u003e\n\u003cp\u003eThe four stages are embryoid body formation using Medium A, neural induction using Medium B, neural expansion after matrix embedding using Medium C, and orbital culture for organoid growth and maturation using Medium D.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003eWhat culture vessels are required for the workflow?\u003c\/summary\u003e\n\u003cp\u003eThe described protocol begins with a 96-well low-attachment U-bottom plate for embryoid body formation. Developing organoids are subsequently transferred to a 24-well low-attachment plate for neural induction, matrix embedding, expansion, and maturation.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003eIs extracellular matrix embedding required?\u003c\/summary\u003e\n\u003cp\u003eYes. The documented workflow embeds the developing organoids in matrix during Day 11–13 before culture in Medium C. The embedded organoids subsequently enter orbital maturation culture.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003eWhat orbital shaker speed is recommended for brain organoid maturation?\u003c\/summary\u003e\n\u003cp\u003eThe protocol specifies orbital shaking at 65–75 rpm from Day 14 during culture in Cerebral Organoid Induction Medium D.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003eHow frequently should the cerebral organoid medium be changed?\u003c\/summary\u003e\n\u003cp\u003eThe documented protocol specifies medium replacement every other day throughout the four-stage differentiation workflow.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003eWhich neural markers were detected in the cerebral organoids?\u003c\/summary\u003e\n\u003cp\u003eThe product data show immunofluorescence staining for TUJ, PAX6, CTIP2, and FOXG1, representing neuronal, neural progenitor, cortical, and forebrain-associated characteristics.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003eCan these organoids be used as a human brain development model?\u003c\/summary\u003e\n\u003cp\u003eThe cerebral organoids are intended as research models for investigating early human neural development, cortical-like tissue formation, forebrain-associated differentiation, and related three-dimensional neural biology.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003eCan the kit be used for disease modeling and drug screening?\u003c\/summary\u003e\n\u003cp\u003eHuman iPSC-derived cerebral organoids may support research involving disease modeling, phenotype comparison, compound evaluation, and neurotoxicity studies. Each application requires independent assay development, suitable controls, and validation for the selected cell line and experimental endpoint.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003eIs this product intended for clinical or diagnostic use?\u003c\/summary\u003e\n\u003cp\u003eNo. XR Cerebral Organoid Differentiation Kit is intended for research use only and is not intended for diagnostic, therapeutic, or clinical use.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cp\u003e\u003cem\u003eFor Research Use Only. Not intended for diagnostic, therapeutic, or clinical applications.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"XRbio","offers":[{"title":"1Kit","offer_id":52798307106997,"sku":"XR-iVasLung-Kit","price":0.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0521\/5312\/2997\/files\/2_414a6be8-c957-4c26-8472-76d0afe925d5.jpg?v=1784008170","url":"https:\/\/biofargo.com\/products\/xr-ipsc-derived-vascularized-lung-organoid-differentiation-kit","provider":"Biofargo","version":"1.0","type":"link"}